Close Menu

NEW YORK (GenomeWeb) – Drug discovery firm Immuneering is teaming with the UK-based Dementia Discovery Fund in an effort to identify new drug targets and candidates for patients with Alzheimer's disease.

The Dementia Discovery Fund, or DDF, said today that it will spend $1.3 million to use Immuneering's drug discovery platform to analyze public data sets on Alzheimer's patients. DDF and Immuneering hope to generate new molecular entities for potential treatment of the neurodegenerative disease.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.

Jul
09
Sponsored by
Illumina

In this webinar, Dr. Charlie Johnson, founder of the Texas A&M AgriLife Genomics and Bioinformatics Service, will share how his team is utilizing Illumina’s DRAGEN informatics platform in its high-throughput agrigenomics research program.